NO996439D0 - Proliposompulvere for inhalering stabilisert med tokoferol - Google Patents

Proliposompulvere for inhalering stabilisert med tokoferol

Info

Publication number
NO996439D0
NO996439D0 NO996439A NO996439A NO996439D0 NO 996439 D0 NO996439 D0 NO 996439D0 NO 996439 A NO996439 A NO 996439A NO 996439 A NO996439 A NO 996439A NO 996439 D0 NO996439 D0 NO 996439D0
Authority
NO
Norway
Prior art keywords
tocopherol
inhalation
stabilized
proliposome powders
proliposome
Prior art date
Application number
NO996439A
Other languages
English (en)
Other versions
NO996439L (no
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996439D0 publication Critical patent/NO996439D0/no
Publication of NO996439L publication Critical patent/NO996439L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO996439A 1997-06-27 1999-12-23 Proliposompulvere for inhalering stabilisert med tokoferol NO996439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Publications (2)

Publication Number Publication Date
NO996439D0 true NO996439D0 (no) 1999-12-23
NO996439L NO996439L (no) 2000-02-28

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996439A NO996439L (no) 1997-06-27 1999-12-23 Proliposompulvere for inhalering stabilisert med tokoferol

Country Status (18)

Country Link
EP (1) EP1001749A1 (no)
JP (1) JP2002510311A (no)
KR (1) KR20010014163A (no)
CN (1) CN1260713A (no)
AU (1) AU729100B2 (no)
BR (1) BR9810280A (no)
CA (1) CA2295028A1 (no)
EE (1) EE9900601A (no)
HU (1) HUP0003207A3 (no)
ID (1) ID23192A (no)
IL (1) IL133478A0 (no)
IS (1) IS5304A (no)
NO (1) NO996439L (no)
NZ (1) NZ501672A (no)
PL (1) PL337723A1 (no)
SK (1) SK184899A3 (no)
TR (1) TR199903271T2 (no)
WO (1) WO1999000111A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138310A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138311A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
JP5846711B2 (ja) * 2005-06-09 2016-01-20 メダ アーベー 炎症性疾患の治療のための方法及び組成物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
BR112015027824B1 (pt) * 2013-05-06 2021-06-08 Dsm Ip Assets B.V. composição na forma de pó, processo para produção da mesma, uso de uma composição na forma de pó e formulação líquida
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
NO996439L (no) 2000-02-28
AU7945698A (en) 1999-01-19
TR199903271T2 (en) 2000-08-21
WO1999000111A1 (en) 1999-01-07
CN1260713A (zh) 2000-07-19
BR9810280A (pt) 2000-09-12
NZ501672A (en) 2001-06-29
EE9900601A (et) 2000-08-15
PL337723A1 (en) 2000-08-28
HUP0003207A2 (hu) 2001-02-28
CA2295028A1 (en) 1999-01-07
SK184899A3 (en) 2000-05-16
HUP0003207A3 (en) 2001-03-28
JP2002510311A (ja) 2002-04-02
IS5304A (is) 1999-12-15
EP1001749A1 (en) 2000-05-24
ID23192A (id) 2000-03-23
IL133478A0 (en) 2001-04-30
AU729100B2 (en) 2001-01-25
KR20010014163A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
NO972847D0 (no) Proliposompulvere for inhalering
EE04420B1 (et) Pulberinhalaator
NO990272L (no) Pulver-inhalator
PL340284A1 (en) Modified polypeptides dependent on vitamin k
DE69708327D1 (de) Pulverinhalator
PL334447A1 (en) Inhaler
PL335690A1 (en) Inhaler
PL335701A1 (en) Inhaler
AU135548S (en) Inhaler
AU135120S (en) Inhaler
IS2703B (is) Innöndunartæki
NO996439D0 (no) Proliposompulvere for inhalering stabilisert med tokoferol
GB9826783D0 (en) Inhalation powders
FR2763507B1 (fr) Inhalateur
GB9815505D0 (en) Polypeptide derivatives
DE69824327D1 (de) Inhalationsgerät
NO20003182L (no) FremgangsmÕte for inhalering av pulverstoffer
GB2329523B (en) Thermally Sensitive Controls
GB0211908D0 (en) Breathable gas mixtures
SE9703829D0 (sv) Powder inhaleri
FI964489A0 (fi) Jauheinhalaattori
GB9720594D0 (en) Inhaler
GB9800862D0 (en) Inhaler
SE9603353D0 (sv) Powder inhaler III
SE9603355D0 (sv) Powder inhaler V

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application